Taking into account cultural differences between Asian and Western patients, this book focuses on delivery of effective treatment at an early stage in psychosis, especially for young people. It pays particular attention to early intervention programmes established in Hong Kong and Singapore, and assesses recent developments in Korea, Japan and other countries. The volume covers approaches in the management of psychosis, including pathway to care, stigma and interventions. With reference to the experiences of frontline practitioners, research findings and theories, it highlights the practical needs in non-Western healthcare settings. Culturally relevant discussions on recovery, relapse, self-harm and comorbid substance abuse are discussed. It also covers case studies to illustrate challenges and strategies in managing early psychosis.

This book reviews the descriptive features of psychotic symptoms in various medical conditions (psychiatric, early psychosis, general medical, neurological and dementia), non-medical settings (individuals without the need for care or at high risk for psychosis) and age groups (children and adolescents, adults, older adults). Similarly, the perspectives of many disciplines are provided (history, psychiatry, psychology, psychopathology, neurology, phenomenological philosophy) so that readers may become familiar with different approaches that are used to define, evaluate and categorize psychosis, at times independently of clinical diagnosis. This book is a resource book for those requiring an understanding of clinical and conceptual issues associated with psychosis, with chapters written by academics and clinicians who are leaders in their respective fields. The book also provides a guide regarding the methods of assessment for psychosis and its symptoms, with 120 rating scales, which are described and evaluated. The Assessment of Psychosis will be particularly useful to the clinical and research community, but also to readers interested in individual differences and human psychopathology.

Increasing interest over recent years in the study of the influences of environment and genetic factors on behavioural disorder has come from a wide range of disciplines. These studies have subsequently been focused through the foundation of the Society for the Study of Behavioural Phenotypes, which forms the basis for assimilating new information and coordinating future research in this field. This volume from founder members of the society presents a distillation of thinking and reviews appropriate measurement schedules. Including research findings, explanation of concepts, genetic scientific techniques and methodological issues, this work will be welcomed by those with an interest in behavioural disorder at every level.

There has been a growing trend in psychiatry to emphasize pharmacological approaches in the treatment of schizophrenia. Despite the considerable influence of psychosocial factors on the course of the disorder, relatively little emphasis has been placed on psychosocial treatment approaches. The aim of the book is to provide authoritative information on a broad spectrum of treatment approaches to improve role functioning and coping skills. Taking into account results of long-term outcome studies carried out in recent years, this book brings together a diversity of controlled research efforts conducted by leading experts in their specific fields. Considering that the major disability attributed to this illness is impairment in social and vocational role functioning, the authors substantiate with efficacious data their theory that antipsychotic medication alone is insufficient in the treatment of patients.

"The Peacemakers Student Handbook consists of handouts and worksheets that students complete throughout the program. The handbook also includes copies of the original stories that are in the Leader2s Guide. All the pages from the Student Handbook appear in the Leader2s Guide and include original illustrations created specifically for children in the target age group."--Publisher's website (www.solution-tree.com).

Recent studies regarding the neuropathology of specific neurological disorders suggest that both neurodevelopmental and neurodegenerative processes may play a role. However, in contrast to the neurodegeneration seen in neurological disorders such as Parkinson's and Alzheimer's disease, the term "neuroprogression" has been used to describe the neurodevelopmental aspect of pathological brain re-wiring that takes place in the context of severe psychiatric disorders, such as schizophrenia or bipolar disorder. Within psychiatry, patients with severe psychopathology, such as those depressed patients who eventually commit suicide, have been shown to present with increased inflammatory markers in the brain. A similar increase in inflammatory markers is also found in patients with bipolar disorders and schizophrenia. Thus, oxidative stress, inflammation, and changes in growth factors are thought to be the pathways of neuroprogression. Neuroprogression in Psychiatry provides a comprehensive summary of the current developments in the emerging field of neuroprogression. With contributions by leading researchers in the field, this book examines the role of neuroprogression across a wide range of specific psychiatric disorders, with chapters included on major depressive disorder, anxiety disorder, post-traumatic stress disorder, substance abuse, schizophrenia, and bipolar disorder.

Towards the end of the twentieth century, the solution to mental illness seemed to be found. It lay in biological solutions, focusing on mental illness as a problem of the brain, to be managed or improved through drugs. We entered the 'Prozac Age' and believed we had moved on definitively from the time of frontal lobotomies to an age of good and successful mental healthcare. Biological psychiatry had triumphed. Except maybe it hadn't. Starting with surprising evidence from the World Health Organisation that suggests people recover better from mental illness in a developing country than in the first world, Doctoring the Mind asks the question: how good are our mental health services, really? Richard Bentall picks apart the science that underlies current psychiatric practice across the US and UK. Arguing passionately for a future of mental health treatment that focuses as much on patients as individuals as on the brain itself, this is a book set to redefine our understanding of the treatment of madness in the twenty-first century.